FGFR1 - Comprehensive Cross-Database Identifier and Functional Mapping Reference
Section 1: Gene Identifiers
Primary Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC ID | HGNC:3688 | Approved symbol |
| HGNC Symbol | FGFR1 | Fibroblast growth factor receptor 1 |
| Ensembl Gene | ENSG00000077782 | Human gene |
| NCBI Entrez Gene | 2260 | NCBI gene ID |
| OMIM | 136350 | Gene/Locus MIM |
| Status | Approved | Protein-coding gene |
Genomic Location (GRCh38)
| Attribute | Value |
|---|
| Chromosome | 8 |
| Cytogenetic Band | 8p11.23 |
| Start Position | 38,400,215 |
| End Position | 38,468,834 |
| Strand | Minus (-) |
| Biotype | protein_coding |
Gene Names and Aliases
| Type | Names |
|---|
| Approved Name | Fibroblast growth factor receptor 1 |
| Previous Names | Fms-related tyrosine kinase 2 |
| Previous Symbols | FLT2, KAL2 |
| Aliases | H2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331 |
Gene Groups
- Receptor tyrosine kinases
- CD molecules
- I-set domain containing
Section 2: Transcript Identifiers
Summary
- Total Ensembl Transcripts: 73
- Protein-coding transcripts: 38
- CCDS IDs: 9
Ensembl Transcripts (All 73)
| Transcript ID | Biotype | Start | End |
|---|
| ENST00000447712 | protein_coding | 38411143 | 38468635 |
| ENST00000397091 | protein_coding | 38411138 | 38468641 |
| ENST00000703405 | protein_coding | 38411138 | 38468834 |
| ENST00000341462 | protein_coding | 38411143 | 38468601 |
| ENST00000326324 | protein_coding | 38412732 | 38468616 |
| ENST00000335922 | protein_coding | 38412731 | 38468621 |
| ENST00000356207 | protein_coding | 38412730 | 38468616 |
| ENST00000397103 | protein_coding | 38412934 | 38457503 |
| ENST00000397108 | protein_coding | 38413522 | 38467724 |
| ENST00000397113 | protein_coding | 38412728 | 38467900 |
| ENST00000413133 | protein_coding | 38429720 | 38467712 |
| ENST00000425967 | protein_coding | 38411642 | 38467701 |
| ENST00000434187 | protein_coding | 38428363 | 38466695 |
| ENST00000440174 | protein_coding | 38457442 | 38463400 |
| ENST00000525001 | protein_coding | 38424549 | 38467842 |
| ENST00000526742 | protein_coding | 38426158 | 38467804 |
| ENST00000529552 | protein_coding | 38426174 | 38467845 |
| ENST00000530568 | protein_coding | 38428012 | 38466663 |
| ENST00000532791 | protein_coding | 38411231 | 38468622 |
| ENST00000533668 | protein_coding | 38424546 | 38467707 |
| ENST00000683765 | protein_coding | 38411642 | 38468601 |
| ENST00000683815 | protein_coding | 38412732 | 38468633 |
| ENST00000684654 | protein_coding | 38412732 | 38468633 |
| ENST00000857933 | protein_coding | 38412726 | 38468641 |
| ENST00000857934 | protein_coding | 38412730 | 38468635 |
| ENST00000857935 | protein_coding | 38412848 | 38468635 |
| ENST00000857936 | protein_coding | 38412848 | 38468635 |
| ENST00000857937 | protein_coding | 38412848 | 38468633 |
| ENST00000857938 | protein_coding | 38412730 | 38468128 |
| ENST00000857939 | protein_coding | 38412848 | 38467712 |
| ENST00000857940 | protein_coding | 38412732 | 38459212 |
| ENST00000934569 | protein_coding | 38411143 | 38468708 |
| ENST00000934570 | protein_coding | 38411229 | 38468634 |
| ENST00000934571 | protein_coding | 38412813 | 38468633 |
| ENST00000934572 | protein_coding | 38412736 | 38468255 |
| ENST00000934573 | protein_coding | 38411131 | 38466638 |
| ENST00000965843 | protein_coding | 38412869 | 38466638 |
| ENST00000965844 | protein_coding | 38412869 | 38461255 |
| ENST00000397090 | retained_intron | 38429521 | 38468150 |
| ENST00000464163 | retained_intron | 38422744 | 38424621 |
| ENST00000466021 | retained_intron | 38417313 | 38422044 |
| ENST00000470826 | retained_intron | 38423313 | 38468308 |
| ENST00000474970 | retained_intron | 38426127 | 38429811 |
| ENST00000475621 | retained_intron | 38421708 | 38426181 |
| ENST00000496296 | retained_intron | 38424017 | 38468635 |
| ENST00000524528 | retained_intron | 38412962 | 38420550 |
| ENST00000526570 | retained_intron | 38412848 | 38430820 |
| ENST00000527114 | retained_intron | 38414779 | 38420344 |
| ENST00000527745 | retained_intron | 38417407 | 38420044 |
| ENST00000532386 | retained_intron | 38424683 | 38430002 |
| ENST00000533619 | retained_intron | 38414613 | 38417514 |
| ENST00000674217 | retained_intron | 38417918 | 38424623 |
| ENST00000674474 | retained_intron | 38412880 | 38468152 |
| ENST00000682398 | retained_intron | 38412968 | 38417734 |
| ENST00000682770 | retained_intron | 38424217 | 38426585 |
| ENST00000683132 | retained_intron | 38412924 | 38416413 |
| ENST00000683276 | retained_intron | 38423692 | 38468601 |
| ENST00000683795 | retained_intron | 38423727 | 38468601 |
| ENST00000683948 | retained_intron | 38412728 | 38468601 |
| ENST00000484370 | nonsense_mediated_decay | 38426179 | 38457446 |
| ENST00000487647 | nonsense_mediated_decay | 38415993 | 38457446 |
| ENST00000531196 | nonsense_mediated_decay | 38413466 | 38415923 |
| ENST00000619564 | nonsense_mediated_decay | 38411139 | 38468834 |
| ENST00000649678 | nonsense_mediated_decay | 38400215 | 38467707 |
| ENST00000674189 | nonsense_mediated_decay | 38411627 | 38468165 |
| ENST00000674235 | nonsense_mediated_decay | 38419533 | 38428435 |
| ENST00000674380 | nonsense_mediated_decay | 38411431 | 38468132 |
| ENST00000480571 | protein_coding_CDS_not_defined | 38465514 | 38466196 |
| ENST00000496629 | protein_coding_CDS_not_defined | 38465413 | 38466663 |
| ENST00000526688 | protein_coding_CDS_not_defined | 38412085 | 38413976 |
| ENST00000527203 | protein_coding_CDS_not_defined | 38424528 | 38457476 |
| ENST00000530701 | protein_coding_CDS_not_defined | 38421843 | 38457532 |
| ENST00000533301 | protein_coding_CDS_not_defined | 38400536 | 38401683 |
RefSeq Transcripts (Human FGFR1 - chr8)
| RefSeq ID | Type | Status | MANE Select |
|---|
| NM_023110 | mRNA | REVIEWED | Yes (Canonical) |
| NM_015850 | mRNA | REVIEWED | No |
| NM_023105 | mRNA | REVIEWED | No |
| NM_023106 | mRNA | REVIEWED | No |
| NM_001174063 | mRNA | REVIEWED | No |
| NM_001174064 | mRNA | REVIEWED | No |
| NM_001174065 | mRNA | REVIEWED | No |
| NM_001174066 | mRNA | REVIEWED | No |
| NM_001174067 | mRNA | REVIEWED | No |
| NM_001354367 | mRNA | REVIEWED | No |
| NM_001354368 | mRNA | REVIEWED | No |
| NM_001354369 | mRNA | REVIEWED | No |
| NM_001354370 | mRNA | REVIEWED | No |
| NM_001410922 | mRNA | REVIEWED | No |
CCDS IDs (9 total)
| CCDS ID |
|---|
| CCDS6107 |
| CCDS43730 |
| CCDS43731 |
| CCDS43732 |
| CCDS55221 |
| CCDS55222 |
| CCDS94283 |
| CCDS94284 |
| CCDS94285 |
Exons for Canonical Transcript ENST00000447712 (18 exons)
| Exon ID | Start | End | Strand |
|---|
| ENSE00001911865 | 38467981 | 38468635 | - |
| ENSE00003610788 | 38457356 | 38457534 | - |
| ENSE00001316315 | 38429682 | 38429948 | - |
| ENSE00003551643 | 38428346 | 38428435 | - |
| ENSE00003614250 | 38427921 | 38428093 | - |
| ENSE00003683948 | 38426122 | 38426245 | - |
| ENSE00003501167 | 38424509 | 38424699 | - |
| ENSE00003510418 | 38421797 | 38421941 | - |
| ENSE00003528389 | 38419533 | 38419735 | - |
| ENSE00003489763 | 38418228 | 38418373 | - |
| ENSE00003614946 | 38417870 | 38417991 | - |
| ENSE00003644071 | 38417306 | 38417416 | - |
| ENSE00003523010 | 38415870 | 38416060 | - |
| ENSE00003576378 | 38414779 | 38414901 | - |
| ENSE00003597475 | 38414559 | 38414629 | - |
| ENSE00003680911 | 38414152 | 38414289 | - |
| ENSE00003611337 | 38413918 | 38414023 | - |
| ENSE00001630314 | 38411143 | 38413804 | - |
Section 3: Protein Identifiers
Primary Protein Identifiers
| Database | Identifier | Description |
|---|
| UniProt (Canonical, Reviewed) | P11362 | Fibroblast growth factor receptor 1 |
| UniProt (Isoform) | A0A0S2Z3Q6 | Unreviewed |
| UniProt (Isoform) | A0A0S2Z3T4 | Unreviewed |
| UniProt (Isoform) | A0A0S2Z3T9 | Unreviewed |
| UniProt (Isoform) | A0A3B3ISD1 | Unreviewed |
| UniProt (Isoform) | A0A6I8PRY1 | Unreviewed |
| UniProt (Isoform) | A0A6I8PTV4 | Unreviewed |
| UniProt (Isoform) | A0A804HIF1 | Unreviewed |
| UniProt (Isoform) | A0A8I3B1S4 | Unreviewed |
| UniProt (Isoform) | A0A994J419 | Unreviewed |
| UniProt (Isoform) | B5A958 | Unreviewed |
| UniProt (Isoform) | C9J1L5 | Unreviewed |
| UniProt (Isoform) | C9J205 | Unreviewed |
| UniProt (Isoform) | E7EU09 | Unreviewed |
| UniProt (Isoform) | E9PKF2 | Unreviewed |
| UniProt (Isoform) | E9PKV7 | Unreviewed |
| UniProt (Isoform) | E9PKX3 | Unreviewed |
| UniProt (Isoform) | E9PN14 | Unreviewed |
| UniProt (Isoform) | E9PNM3 | Unreviewed |
| UniProt (Isoform) | E9PQ40 | Unreviewed |
| UniProt (Isoform) | H0YE20 | Unreviewed |
Total UniProt Entries: 21
Canonical Protein Properties (P11362)
| Property | Value |
|---|
| Molecular Weight | 91,868 Da |
| Sequence Length | 822 amino acids |
| Alternative Names | Basic fibroblast growth factor receptor 1, Fms-like tyrosine kinase 2, N-sam, Proto-oncogene c-Fgr |
RefSeq Protein Accessions
| RefSeq Protein | Transcript |
|---|
| NP_075598 | NM_023110 (MANE Select) |
| NP_056934 | NM_015850 |
| NP_075593 | NM_023105 |
| NP_075594 | NM_023106 |
| NP_001167534 | NM_001174063 |
| NP_001167535 | NM_001174064 |
| NP_001167536 | NM_001174065 |
| NP_001167537 | NM_001174066 |
| NP_001167538 | NM_001174067 |
| NP_001341296 | NM_001354367 |
| NP_001341297 | NM_001354368 |
| NP_001341298 | NM_001354369 |
| NP_001341299 | NM_001354370 |
| NP_001397851 | NM_001410922 |
Protein Domains and Families (InterPro - 16 entries)
| InterPro ID | Name | Type |
|---|
| IPR050122 | RTK | Family |
| IPR016248 | FGF_rcpt_fam | Family |
| IPR028174 | FGF_rcpt_1 | Domain |
| IPR000719 | Prot_kinase_dom | Domain |
| IPR001245 | Ser-Thr/Tyr_kinase_cat_dom | Domain |
| IPR020635 | Tyr_kinase_cat_dom | Domain |
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR013151 | Immunoglobulin_dom | Domain |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR008266 | Tyr_kinase_AS | Active_site |
| IPR017441 | Protein_kinase_ATP_BS | Binding_site |
Section 4: Structure Identifiers
Summary
- Total PDB Structures: 81
- X-ray Diffraction: 77
- Solution NMR: 2
- Cryo-EM: 2
Experimental Structures (All 81 PDB entries)
| PDB ID | Method | Resolution | Title |
|---|
| 1AGW | X-RAY | 2.4 Å | TK domain with SU4984 inhibitor |
| 1CVS | X-RAY | 2.8 Å | Dimeric FGF2-FGFR1 complex |
| 1EVT | X-RAY | 2.8 Å | FGF1 with FGFR1 ligand binding domain |
| 1FGI | X-RAY | 2.5 Å | TK domain with SU5402 inhibitor |
| 1FGK | X-RAY | 2.0 Å | TK domain |
| 1FQ9 | X-RAY | 3.0 Å | Ternary FGF2-FGFR1-heparin complex |
| 1XR0 | NMR | - | SNT PTB domain interactions |
| 2CR3 | NMR | - | First Ig-like domain |
| 2FGI | X-RAY | 2.5 Å | TK domain with PD173074 |
| 3C4F | X-RAY | 2.07 Å | TK with 7-azaindole compound |
| 3DPK | X-RAY | 1.95 Å | cFMS TK with pyridopyrimidinone |
| 3GQI | X-RAY | 2.5 Å | Activated RTK with substrates |
| 3GQL | X-RAY | 2.8 Å | Activated RTK with substrates |
| 3JS2 | X-RAY | 2.2 Å | Kinase with thienylnicotinic acid |
| 3KRJ | X-RAY | 2.1 Å | cFMS TK with imidazole compound |
| 3KRL | X-RAY | 2.4 Å | cFMS TK with furan compound |
| 3KXX | X-RAY | 3.2 Å | Mutant FGFR1 |
| 3KY2 | X-RAY | 2.7 Å | Kinase domain |
| 3OJV | X-RAY | 2.6 Å | FGF1 with FGFR1c ectodomain |
| 3RHX | X-RAY | 2.01 Å | Kinase with ARQ 069 |
| 3TT0 | X-RAY | 2.8 Å | Kinase with BGJ398 (Infigratinib) |
| 4F63 | X-RAY | 2.55 Å | Kinase with compound 1 |
| 4F64 | X-RAY | 2.05 Å | Kinase with compound 6 |
| 4F65 | X-RAY | 2.26 Å | Kinase with compound 8 |
| 4NK9 | X-RAY | 2.57 Å | Kinase with pyrazolaminopyrimidine 1 |
| 4NKA | X-RAY | 2.19 Å | Kinase with pyrazolaminopyrimidine 2 |
| 4NKS | X-RAY | 2.5 Å | Kinase with pyrazolaminopyrimidine 3 |
| 4RWI | X-RAY | 2.29 Å | V561M gatekeeper mutation, apo |
| 4RWJ | X-RAY | 2.49 Å | With AZD4547 |
| 4RWK | X-RAY | 2.98 Å | V561M with AZD4547 |
| 4RWL | X-RAY | 2.19 Å | With E3810 |
| 4UWB | X-RAY | 2.31 Å | Kinase with JK-P5 |
| 4UWC | X-RAY | 1.96 Å | Kinase with JK-P3 |
| 4UWY | X-RAY | 2.31 Å | Apo structure |
| 4V01 | X-RAY | 2.33 Å | With ponatinib |
| 4V04 | X-RAY | 2.12 Å | With ponatinib |
| 4V05 | X-RAY | 2.57 Å | With AZD4547 |
| 4WUN | X-RAY | 1.65 Å | With AZD4547 (high resolution) |
| 4ZSA | X-RAY | 2.0 Å | Kinase with compound 7n |
| 5A46 | X-RAY | 2.63 Å | With dovitinib |
| 5A4C | X-RAY | 2.09 Å | Ligand complex |
| 5AM6 | X-RAY | 1.96 Å | Native with inhibitor |
| 5AM7 | X-RAY | 1.96 Å | Mutant with inhibitor |
| 5B7V | X-RAY | 2.15 Å | With CH5183284 |
| 5EW8 | X-RAY | 1.63 Å | With JNJ-4275693 |
| 5FLF | X-RAY | 2.58 Å | Disease linked mutation |
| 5O49 | X-RAY | 1.91 Å | With covalent inhibitor |
| 5O4A | X-RAY | 2.01 Å | With covalent inhibitor |
| 5UQ0 | X-RAY | 2.3 Å | With fragment compound |
| 5UR1 | X-RAY | 2.2 Å | With SN37333 |
| 5VND | X-RAY | 2.2 Å | With H3B-6527 |
| 5W21 | X-RAY | 3.0 Å | FGF23-FGFR1c-aKlotho ternary complex |
| 5W59 | X-RAY | 2.5 Å | Monomeric FGF9 with FGFR1c |
| 5Z0S | X-RAY | 2.45 Å | With novel inhibitor |
| 5ZV2 | X-RAY | 2.86 Å | With lenvatinib |
| 6C18 | X-RAY | 2.3 Å | With SN37115 |
| 6C19 | X-RAY | 2.12 Å | With SN36985 |
| 6C1B | X-RAY | 2.0 Å | With SN37118 |
| 6C1C | X-RAY | 2.15 Å | With SN37116 |
| 6C1O | X-RAY | 2.29 Å | With FIIN-1 |
| 6ITJ | X-RAY | 1.99 Å | With compound 3 |
| 6MZQ | X-RAY | 2.0 Å | With TAS-120 (futibatinib) reversible |
| 6MZW | X-RAY | 2.2 Å | With TAS-120 (futibatinib) covalent |
| 6NVL | X-RAY | 2.7 Å | With acrylamide compound |
| 6P68 | X-RAY | 2.9 Å | With compound 22 |
| 6P69 | X-RAY | 2.2 Å | With compound 11 |
| 7OZB | X-RAY | 1.71 Å | With compound 38 |
| 7OZD | X-RAY | 1.82 Å | With compound 34 |
| 7OZF | X-RAY | 1.82 Å | With compound 19 |
| 7TNH | X-RAY | 2.7 Å | CSF1R kinase with DP-6233 |
| 7WCL | X-RAY | 2.5 Å | With pemigatinib |
| 7YSH | CRYO-EM | 2.74 Å | FGF23-FGFR1c-aKlotho-HS quaternary |
| 8JMZ | X-RAY | 1.99 Å | With sulfatinib |
| 8JQI | CRYO-EM | 4.1 Å | PLCγ2 with FGFR1 kinase |
| 8XLO | X-RAY | 2.36 Å | With CXF-007 |
| 8XZ7 | X-RAY | 1.75 Å | With compound 10h |
| 8Y22 | X-RAY | 2.79 Å | With compound 9g |
| 8YKI | X-RAY | 2.79 Å | With tasurgratinib |
| 9CD5 | X-RAY | 2.94 Å | With TYRA-300 |
| 9UHC | X-RAY | 1.88 Å | With compound 9p |
| 9UHI | X-RAY | 1.76 Å | With compound 9o |
AlphaFold Predicted Structure
| Model ID | pLDDT (Global) | Sequence Length | Fraction Very High Confidence |
|---|
| AF-P11362-F1 | 74.30 | 6446 | 0.34 (34%) |
Section 5: Cross-Species Orthologs
| Organism | Ensembl Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000031565 | Fgfr1 | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000016050 | Fgfr1 | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000011027 | fgfr1a | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000011190 | fgfr1b | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000104015 | fgfr1bl | protein_coding |
| Fruit fly (Drosophila) | No direct ortholog | - | See paralogs |
| Worm (C. elegans) | No direct ortholog | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - |
Note: FGFR1 is a vertebrate-specific receptor. Invertebrates like Drosophila have related FGF receptors (heartless/breathless) but are not direct orthologs.
Section 6: Clinical Variants & AI Predictions
ClinVar Summary
- Total FGFR1 variants in ClinVar: 1,366+
Pathogenic/Likely Pathogenic Variants (TOP 50)
| ClinVar ID | HGVS | Classification | Condition |
|---|
| 16279 | c.755C>G (p.Pro252Arg) | Pathogenic | Pfeiffer syndrome |
| 16303 | c.749G>A (p.Arg250Gln) | Pathogenic | Craniosynostosis |
| 235084 | c.749G>C (p.Arg250Pro) | Pathogenic | Craniosynostosis |
| 16296 | c.1825C>T (p.Arg609Ter) | Pathogenic | HH2 |
| 224896 | c.1638C>A (p.Asn546Lys) | Pathogenic | Oncogenic |
| 224897 | c.1966A>G (p.Lys656Glu) | Pathogenic | Oncogenic |
| 132646 | c.790A>C (p.Asn264His) | Pathogenic | OGD |
| 132647 | c.1460G>A (p.Gly487Asp) | Pathogenic | OGD |
| 132648 | c.2084C>T (p.Thr695Ile) | Pathogenic | Cancer |
| 16285 | c.499G>T (p.Ala167Ser) | Pathogenic | HH2 |
| 16300 | c.2164C>T (p.Pro722Ser) | Pathogenic | OGD |
| 16301 | c.2292G>T (p.Gln764His) | Pathogenic | OGD |
| 377227 | c.1468G>A (p.Gly490Arg) | Pathogenic | HH2 |
| 379237 | c.2152C>G (p.Arg718Gly) | Pathogenic | OGD |
| 265428 | c.1864C>G (p.Arg622Gly) | Pathogenic | HH2 |
| 280606 | c.1431-1G>A | Pathogenic | Splicing |
| 1065343 | c.745+2T>A | Likely Pathogenic | Splicing |
| 1074220 | c.979_983del (p.His327fs) | Pathogenic | Frameshift |
| 1184446 | c.2122G>T (p.Glu708Ter) | Pathogenic | Nonsense |
| 1208776 | c.962_963del (p.Lys321fs) | Pathogenic | Frameshift |
| 1212943 | c.1936C>T (p.Arg646Trp) | Likely Pathogenic | Missense |
| 1338306 | c.2223del (p.Ser742fs) | Pathogenic | Frameshift |
| 1338919 | c.2187-1G>A | Pathogenic | Splicing |
| 1341672 | c.1855-1G>A | Pathogenic | Splicing |
| 1418780 | c.1265dup (p.Leu423fs) | Pathogenic | Frameshift |
| 1709350 | c.1969dup (p.Thr657fs) | Pathogenic | Frameshift |
| 1801171 | c.246_247del (p.Glu84fs) | Pathogenic | Frameshift |
| 1997422 | c.111del (p.Val38fs) | Pathogenic | Frameshift |
| 2011123 | c.625del (p.Arg209fs) | Pathogenic | Frameshift |
| 2029325 | c.780del (p.Leu261fs) | Pathogenic | Frameshift |
| 2097346 | c.1568_1569dup (p.Asp524fs) | Pathogenic | Frameshift |
| 2105298 | c.2048T>G (p.Val683Gly) | Pathogenic | Missense |
| 2136660 | c.1883A>G (p.Asn628Ser) | Pathogenic | Missense |
| 2136661 | c.302G>T (p.Cys101Phe) | Pathogenic | Missense |
| 2505374 | c.165_171del (p.Arg56fs) | Pathogenic | Frameshift |
| 2505375 | c.355dup (p.Ser119fs) | Pathogenic | Frameshift |
| 2505376 | c.551dup (p.Asn185fs) | Pathogenic | Frameshift |
| 2505377 | c.570G>A (p.Trp190Ter) | Pathogenic | Nonsense |
| 2505378 | c.630T>A (p.Tyr210Ter) | Pathogenic | Nonsense |
| 2505380 | c.925C>T (p.Gln309Ter) | Pathogenic | Nonsense |
| 2505381 | c.1039dup (p.Ile347fs) | Pathogenic | Frameshift |
| 2505383 | c.1081+1G>T | Pathogenic | Splicing |
| 2505385 | c.1285-2A>G | Pathogenic | Splicing |
| 2505391 | c.1553-2A>G | Pathogenic | Splicing |
| 2505392 | c.1589C>G (p.Ser530Ter) | Pathogenic | Nonsense |
| 2505394 | c.1684G>T (p.Glu562Ter) | Pathogenic | Nonsense |
| 2505396 | c.1755C>A (p.Tyr585Ter) | Pathogenic | Nonsense |
| 2505398 | c.1854+1G>A | Pathogenic | Splicing |
| 2505443 | c.1889T>C (p.Leu630Pro) | Pathogenic | Missense |
| 3064126 | c.1988C>G (p.Pro663Arg) | Pathogenic | Missense |
AlphaMissense Predictions
- Total Predicted Variants: 5,386
TOP 50 Predicted Pathogenic (score > 0.5)
| Variant | Position | AM Score | Classification |
|---|
| K820N | 8:38413637 | 0.610 | Likely Pathogenic |
| K820I | 8:38413638 | 0.548 | Ambiguous |
| C806W | 8:38413679 | 0.514 | Ambiguous |
Note: The C-terminal region shows predominantly benign predictions. Kinase domain and ligand-binding regions contain higher pathogenicity predictions.
SpliceAI Predictions
- Total FGFR1 Splice Variants Predicted: 5,160+
High-impact splice predictions occur predominantly at canonical splice sites (GT/AG) with delta scores approaching 1.0.
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways (22 total)
| Pathway ID | Name | Disease Pathway |
|---|
| R-HSA-5654687 | Downstream signaling of activated FGFR1 | No |
| R-HSA-190370 | FGFR1b ligand binding and activation | No |
| R-HSA-190373 | FGFR1c ligand binding and activation | No |
| R-HSA-190374 | FGFR1c and Klotho ligand binding and activation | No |
| R-HSA-5654219 | Phospholipase C-mediated cascade: FGFR1 | No |
| R-HSA-5654688 | SHC-mediated cascade:FGFR1 | No |
| R-HSA-5654689 | PI-3K cascade:FGFR1 | No |
| R-HSA-5654693 | FRS-mediated FGFR1 signaling | No |
| R-HSA-5654726 | Negative regulation of FGFR1 signaling | No |
| R-HSA-5673001 | RAF/MAP kinase cascade | No |
| R-HSA-109704 | PI3K Cascade | No |
| R-HSA-1257604 | PIP3 activates AKT signaling | No |
| R-HSA-375165 | NCAM signaling for neurite out-growth | No |
| R-HSA-445144 | Signal transduction by L1 | No |
| R-HSA-9758919 | Epithelial-Mesenchymal Transition during gastrulation | No |
| R-HSA-9793380 | Formation of paraxial mesoderm | No |
| R-HSA-1839120 | Signaling by FGFR1 amplification mutants | Yes |
| R-HSA-1839122 | Signaling by activated point mutants of FGFR1 | Yes |
| R-HSA-5655302 | Signaling by FGFR1 in disease | Yes |
| R-HSA-8853336 | Signaling by plasma membrane FGFR1 fusions | Yes |
| R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | Yes |
| R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | No |
Gene Ontology Annotations
Biological Process (55 terms) - TOP 20:
| GO ID | Term |
|---|
| GO:0008543 | Fibroblast growth factor receptor signaling pathway |
| GO:0006468 | Protein phosphorylation |
| GO:0018108 | Peptidyl-tyrosine phosphorylation |
| GO:0046777 | Protein autophosphorylation |
| GO:0000165 | MAPK cascade |
| GO:0043410 | Positive regulation of MAPK cascade |
| GO:0008284 | Positive regulation of cell population proliferation |
| GO:0001525 | Angiogenesis |
| GO:0001501 | Skeletal system development |
| GO:0002062 | Chondrocyte differentiation |
| GO:0031175 | Neuron projection development |
| GO:0001764 | Neuron migration |
| GO:0001837 | Epithelial to mesenchymal transition |
| GO:0016477 | Cell migration |
| GO:0030326 | Embryonic limb morphogenesis |
| GO:0048863 | Stem cell differentiation |
| GO:0060038 | Cardiac muscle cell proliferation |
| GO:0048015 | Phosphatidylinositol-mediated signaling |
| GO:0042472 | Inner ear morphogenesis |
| GO:0007605 | Sensory perception of sound |
Molecular Function (11 terms):
| GO ID | Term |
|---|
| GO:0005007 | Fibroblast growth factor receptor activity |
| GO:0004713 | Protein tyrosine kinase activity |
| GO:0005524 | ATP binding |
| GO:0017134 | Fibroblast growth factor binding |
| GO:0008201 | Heparin binding |
| GO:0042802 | Identical protein binding |
| GO:0042803 | Protein homodimerization activity |
| GO:0042169 | SH2 domain binding |
| GO:0090722 | Receptor-receptor interaction |
Cellular Component (12 terms):
| GO ID | Term |
|---|
| GO:0005886 | Plasma membrane |
| GO:0016020 | Membrane |
| GO:0043235 | Receptor complex |
| GO:0005634 | Nucleus |
| GO:0005829 | Cytosol |
| GO:0031410 | Cytoplasmic vesicle |
| GO:0005576 | Extracellular region |
| GO:0098794 | Postsynapse |
| GO:0098978 | Glutamatergic synapse |
Section 8: Protein Interactions & Molecular Networks
STRING Protein-Protein Interactions
- Total Interactions: 4,013+
TOP 50 Highest-Confidence Interactions (Score ≥ 750)
| UniProt ID | Gene | Interaction Score |
|---|
| P11362 | FGFR1 (self) | 999 |
| P55075 | - | 999 |
| P05230 | FGF1 | 998 |
| P08620 | FGF4 | 998 |
| P09038 | FGF2 | 998 |
| P31371 | FGF9 | 998 |
| Q92913 | FGF21 | 998 |
| O15520 | FGF10 | 997 |
| O60258 | FGF18 | 997 |
| P10767 | FGF6 | 997 |
| P11487 | FGF3 | 997 |
| P12034 | FGF5 | 997 |
| P21781 | FGF7 | 997 |
| Q86Z14 | FGF23 | 997 |
| Q9GZV9 | FGF22 | 997 |
| Q9UEF7 | FGF20 | 997 |
| O76093 | FGF8 | 996 |
| O43320 | FGF16 | 995 |
| Q9HCT0 | FGF12 | 995 |
| Q9NP95 | FGF17 | 995 |
| Q8WU20 | FRS2 | 987 |
| Q9NSA1 | FRS3 | 986 |
| P13591 | NCAM1 | 942 |
| P22455 | FGFR4 | 935 |
| P23352 | FGFRL1 | 935 |
| P08908 | 5HT1A | 887 |
| P31431 | SDC4 | 887 |
| Q14449 | GRB14 | 886 |
| P19022 | CDH2 | 885 |
| O95750 | FGFBP1 | 884 |
| P19174 | PLCG1 | 868 |
| Q9UBW7 | ZMYND8 | 866 |
| O75410 | TACC1 | 864 |
| Q15672 | TWIST1 | 847 |
| P14618 | PKM | 842 |
| O14786 | NRP1 | 823 |
| Q9NVK5 | FGFR1OP2 | 818 |
| Q8NFJ6 | NRIP2 | 817 |
| P01116 | KRAS | 816 |
| Q6X4W1 | NIBAN1 | 804 |
| P01133 | EGF | 800 |
| O95684 | FGFR1OP | 788 |
| Q9HC23 | FGFR1-IT1 | 788 |
| P42336 | PIK3CA | 778 |
| P35222 | CTNNB1 | 762 |
| P30968 | GNRHR | 758 |
| Q969F8 | CST3L | 756 |
| P00338 | LDHA | 750 |
| P16070 | CD44 | 745 |
| Q7Z7A1 | CNTRL | 741 |
IntAct Experimentally Validated Interactions
- Total Curated Interactions: 232+
High-Confidence Direct Interactions (Score ≥ 0.8):
| Interaction | Partner Gene | Type | Score |
|---|
| EBI-1028412 | FGF2 | Direct interaction | 0.910 |
| EBI-22229196 | FGF2 | Direct interaction | 0.910 |
| EBI-16017091 | PLCG1 | Phosphorylation | 0.900 |
| EBI-16017120 | PLCG1 | Direct interaction | 0.900 |
| EBI-22229123 | FGF1 | Direct interaction | 0.840 |
| EBI-3647243 | FGF1 | Direct interaction | 0.840 |
Protein Sequence Similarity (DIAMOND)
- Total Similar Proteins: 229+
TOP 20 by Sequence Identity:
| UniProt ID | Description | Identity % | Bitscore |
|---|
| A0M8S8 | FGFR1 isoform | 100.0% | 2803 |
| P08581 | MET | 99.8% | 2813 |
| A0M8R7 | FGFR1 isoform | 99.3% | 2784 |
| P08069 | IGF1R | 97.7% | 2685 |
| P10721 | KIT | 97.8% | 1840 |
| P21802 | FGFR2 | 97.0% | 1615 |
| P21803 | FGFR3 | 97.0% | 1611 |
| P06213 | INSR | 99.5% | 2691 |
| P35918 | VEGFR3 | 95.2% | 2582 |
| P35917 | VEGFR2 | 95.9% | 2650 |
| P35916 | VEGFR1 | 86.8% | 2385 |
| P16234 | PDGFRA | 91.9% | 1964 |
| P09619 | PDGFRB | 90.4% | 1933 |
| O08775 | Fgfr1 (mouse) | 95.2% | 2575 |
| P22182 | FGFRL1 | 80.6% | 1331 |
Structural/Embedding Similarity (ESM2)
- Total Similar Proteins: 59
TOP 20 by ESM2 Similarity:
| UniProt ID | Top Similarity | Avg Similarity |
|---|
| B4HNW4 | 1.0000 | 0.9889 |
| B4QC63 | 1.0000 | 0.9889 |
| B4GBH0 | 1.0000 | 0.9887 |
| P16092 | 0.9999 | 0.9910 |
| P11362 | 0.9999 | 0.9908 |
| Q6AWJ9 | 0.9999 | 0.9891 |
| B4P5Q9 | 0.9999 | 0.9883 |
| Q04589 | 0.9999 | 0.9910 |
| A0JM20 | 0.9998 | 0.9834 |
| Q8QFP9 | 0.9998 | 0.9833 |
| Q498D6 | 0.9998 | 0.9843 |
| Q03142 | 0.9998 | 0.9843 |
| P55144 | 0.9998 | 0.9833 |
| O35158 | 0.9997 | 0.9766 |
| P21802 | 0.9997 | 0.9874 |
| P21803 | 0.9997 | 0.9882 |
| P18461 | 0.9997 | 0.9883 |
| Q32MD9 | 0.9997 | 0.9765 |
| P22607 | 0.9994 | 0.9866 |
| P21804 | 0.9993 | 0.9914 |
Section 9: Transcription Factor Regulatory Data
Note: FGFR1 is NOT a transcription factor, but is regulated by TFs.
Upstream Regulators (TFs that regulate FGFR1)
- Total TF Regulators in CollecTRI: 102+
TOP 50 Transcription Factors Regulating FGFR1:
| TF Gene | Regulation | Confidence |
|---|
| E2F1 | Activation | High |
| E2F4 | Unknown | High |
| KLF9 | Activation | High |
| KLF10 | Repression | High |
| TEAD4 | Activation | High |
| TEAD1 | Activation | Low |
| TGFB1 | Activation | - |
| RB1 | Repression | - |
| FGF2 | Repression | - |
| ATOH1 | Repression | - |
| APLN | Repression | - |
| SP1 | Unknown | High |
| CEBPB | - | High |
| GATA3 | - | High |
| DNMT1 | - | High |
| EZH2 | - | High |
| NFE2L2 | - | High |
| RARA | - | High |
| PAX3 | - | High |
| TCF3 | - | High |
| TAL1 | - | High |
| TBP | - | High |
| TFAP2A | - | High |
| ZBTB16 | - | High |
| SP3 | - | High |
| SP7 | - | High |
| ATF1 | - | High |
| ATOH8 | - | High |
| HINFP | - | High |
| IRF1 | - | High |
| IRF2 | - | High |
| IRF3 | - | High |
| KAT7 | - | High |
| KDM5A | - | High |
| KDM5B | - | High |
| KDM5C | - | High |
| KMT2A | - | High |
| MBD2 | - | High |
| AHR | - | Low |
| AP1 | - | Low |
| ARNT | - | Low |
| ASCL2 | - | Low |
| ASCL4 | - | Low |
| DLX2 | - | Low |
| DNMT3B | - | Low |
| FOXO3 | - | Low |
| GATA4 | - | Low |
| GLI2 | - | Low |
| HOXD4 | - | Low |
| ID1 | - | Low |
Section 10: Drug & Pharmacology Data
ChEMBL Target Summary
| Target ID | Type | Description |
|---|
| CHEMBL3650 | SINGLE PROTEIN | Fibroblast growth factor receptor 1 |
| CHEMBL2095217 | PROTEIN FAMILY | FGFR family |
| CHEMBL2111439 | PROTEIN FAMILY | VEGFR2/FGFR1 dual target |
| CHEMBL5291677 | PPI | Cereblon/FGFR1 |
| CHEMBL5291688 | PPI | VHL/FGFR1 |
FDA-Approved Drugs Targeting FGFR1 (Phase 4)
| ChEMBL ID | Drug Name | Type | Approved Indication |
|---|
| CHEMBL3545376 | ERDAFITINIB | Small molecule | FGFR-altered urothelial cancer |
| CHEMBL1852688 | INFIGRATINIB | Small molecule | Cholangiocarcinoma with FGFR2 fusion |
| CHEMBL4297522 | PEMIGATINIB | Small molecule | Cholangiocarcinoma |
| CHEMBL3701238 | FUTIBATINIB | Small molecule | Cholangiocarcinoma |
| CHEMBL1171837 | PONATINIB | Small molecule | CML, Ph+ ALL |
| CHEMBL535 | SUNITINIB | Small molecule | RCC, GIST |
| CHEMBL1336 | SORAFENIB | Small molecule | HCC, RCC |
| CHEMBL1289601 | LENVATINIB | Small molecule | Thyroid cancer, HCC |
| CHEMBL1289926 | AXITINIB | Small molecule | RCC |
| CHEMBL24828 | VANDETANIB | Small molecule | Medullary thyroid cancer |
| CHEMBL477772 | PAZOPANIB | Small molecule | RCC, STS |
| CHEMBL1289494 | TIVOZANIB | Small molecule | RCC |
| CHEMBL502835 | NINTEDANIB | Small molecule | IPF, NSCLC |
| CHEMBL1946170 | REGORAFENIB | Small molecule | CRC, GIST, HCC |
| CHEMBL1983268 | ENTRECTINIB | Small molecule | NTRK+ solid tumors |
| CHEMBL2105717 | CABOZANTINIB | Small molecule | RCC, HCC, MTC |
| CHEMBL3545311 | BRIGATINIB | Small molecule | ALK+ NSCLC |
| CHEMBL608533 | MIDOSTAURIN | Small molecule | AML with FLT3 |
| CHEMBL1287853 | FEDRATINIB | Small molecule | Myelofibrosis |
| CHEMBL3622821 | UPADACITINIB | Small molecule | RA |
| CHEMBL5416410 | DASATINIB | Small molecule | CML, Ph+ ALL |
| CHEMBL2325741 | CAPIVASERTIB | Small molecule | HR+/HER2- breast cancer |
| CHEMBL1448 | NICLOSAMIDE | Small molecule | Anthelmintic |
Phase 3 Clinical Candidates
| ChEMBL ID | Drug Name | Type |
|---|
| CHEMBL223360 | LINIFANIB | Small molecule |
| CHEMBL2316582 | OLVEREMBATINIB | Small molecule |
| CHEMBL270995 | BRIVANIB ALANINATE | Small molecule |
| CHEMBL274654 | ORANTINIB | Small molecule |
| CHEMBL276711 | SEMAXANIB | Small molecule |
| CHEMBL300138 | ENZASTAURIN | Small molecule |
| CHEMBL377300 | BRIVANIB | Small molecule |
| CHEMBL4297190 | SURUFATINIB | Small molecule |
| CHEMBL483158 | ALISERTIB | Small molecule |
| CHEMBL484 | ADEFOVIR | Small molecule |
| CHEMBL491473 | CEDIRANIB | Small molecule |
| CHEMBL522892 | DOVITINIB | Small molecule |
| CHEMBL572881 | MOTESANIB | Small molecule |
| CHEMBL603469 | LESTAURTINIB | Small molecule |
| CHEMBL91829 | RUBOXISTAURIN | Small molecule |
PharmGKB
| PharmGKB ID | Symbol | VIP Gene | CPIC Guideline |
|---|
| PA28127 | FGFR1 | Yes | No |
Section 11: Expression Profiles
Bgee Expression Summary
| Metric | Value |
|---|
| Expression Pattern | Ubiquitous |
| Total Present Calls | 292 |
| Total Absent Calls | 2 |
| Total Conditions Tested | 294 |
| Max Expression Score | 98.95 |
| Average Expression Score | 90.66 |
| Gold Quality Data Points | 275 |
TOP 30 Tissues by Expression Score
| Rank | Tissue/Cell Type | Score | Quality |
|---|
| 1 | Buccal mucosa cell | 98.95 | Gold |
| 2 | Stromal cell of endometrium | 98.88 | Gold |
| 3 | Calcaneal tendon | 98.84 | Gold |
| 4 | Right ovary | 98.59 | Gold |
| 5 | Paraflocculus | 98.54 | Gold |
| 6 | Left ovary | 98.49 | Gold |
| 7 | Right coronary artery | 98.47 | Gold |
| 8 | Left uterine tube | 98.44 | Gold |
| 9 | Cerebellar hemisphere | 98.42 | Gold |
| 10 | Right hemisphere of cerebellum | 98.38 | Gold |
| 11 | Cerebellar cortex | 98.37 | Gold |
| 12 | Cerebellum | 98.30 | Gold |
| 13 | Descending thoracic aorta | 98.29 | Gold |
| 14 | Body of pancreas | 98.25 | Gold |
| 15 | Ascending aorta | 98.23 | Gold |
| 16 | Thoracic aorta | 98.22 | Gold |
| 17 | Aorta | 98.17 | Gold |
| 18 | Popliteal artery | 98.16 | Gold |
| 19 | Tibial artery | 98.15 | Gold |
| 20 | Gall bladder | 98.11 | Gold |
| 21 | Mucosa of stomach | 98.07 | Gold |
| 22 | Lower esophagus muscularis | 98.06 | Gold |
| 23 | Saphenous vein | 98.05 | Gold |
| 24 | Lower esophagus | 98.02 | Gold |
| 25 | Esophagogastric junction | 98.02 | Gold |
| 26 | Colonic epithelium | 97.94 | Gold |
| 27 | Omental fat pad | 97.90 | Gold |
| 28 | Peritoneum | 97.89 | Gold |
| 29 | Coronary artery | 97.89 | Gold |
| 30 | Tibial nerve | 97.83 | Gold |
Single-Cell Expression Atlas (SCXA) Datasets
| Dataset | Description | Cells |
|---|
| E-MTAB-8142 | Human breast skin cells | 809,675 |
| E-MTAB-7407 | Human fetal liver, skin, kidney | 473,803 |
| E-CURD-126 | Normal and fibrotic lungs | 121,080 |
| E-MTAB-9841 | Mammary epithelial cells | 92,071 |
| E-MTAB-10855 | Lactating mammary gland | 74,404 |
| E-MTAB-10018 | Naive/primed pluripotent stem cells | 37,007 |
| E-MTAB-10885 | Human milk vs breast tissue | 28,628 |
| E-MTAB-11121 | Retinal organoids | 22,253 |
| E-MTAB-5061 | Human pancreas (normal & T2D) | 3,386 |
| E-GEOD-93593 | H1 ESC differentiation | 1,733 |
| E-ENAD-27 | Human islet cells | 1,145 |
| E-CURD-7 | Adult breast epithelial cells | 867 |
| E-ENAD-21 | Adult breast epithelial cells | 867 |
| E-GEOD-75140 | Cerebral organoids | 734 |
Section 12: Disease Associations
Mendelian/Monogenic Diseases (GenCC - 29 associations)
| Disease | OMIM/MONDO | Inheritance | Classification |
|---|
| Pfeiffer syndrome | OMIM:101600 | AD | Definitive |
| Hypogonadotropic hypogonadism 2 ± anosmia (HH2) | OMIM:147950 | AD | Definitive |
| Osteoglophonic dysplasia (OGD) | OMIM:166250 | AD | Definitive |
| Hartsfield-Bixler-Demyer syndrome | OMIM:615465 | AD | Definitive |
| Encephalocraniocutaneous lipomatosis | OMIM:613001 | AD | Definitive |
| Jackson-Weiss syndrome | OMIM:123150 | AD | Strong |
| Kallmann syndrome | ORPHANET:478 | AD | Supportive |
| Trigonocephaly (isolated) | ORPHANET:3366 | AD | Supportive |
| Septo-optic dysplasia spectrum | ORPHANET:3157 | AD | Supportive |
| Tooth agenesis | ORPHANET:99798 | AD | Supportive |
| Holoprosencephaly | ORPHANET:2162 | AR | Supportive |
Orphanet Disease Associations (17 total)
| Orphanet ID | Disease | Type | Gene Count |
|---|
| 2117 | Hartsfield syndrome | Malformation syndrome | 1 |
| 2645 | Osteoglophonic dysplasia | Malformation syndrome | 1 |
| 2396 | Encephalocraniocutaneous lipomatosis | Disease | 2 |
| 478 | Kallmann syndrome | Clinical subtype | 22 |
| 432 | Normosmic congenital HH | Clinical subtype | 18 |
| 3157 | Septo-optic dysplasia spectrum | Malformation syndrome | 7 |
| 3366 | Non-syndromic metopic craniosynostosis | Morphological anomaly | 2 |
| 93258 | Pfeiffer syndrome type 1 | Clinical subtype | 2 |
| 99798 | Oligodontia | Morphological anomaly | 12 |
| 168953 | Myeloid/lymphoid neoplasm with FGFR1 rearrangement | Disease | 1 |
| 314950 | Primary hypereosinophilic syndrome | Disease | 5 |
| 220386 | Semilobar holoprosencephaly | Clinical subtype | 18 |
| 93924 | Lobar holoprosencephaly | Clinical subtype | 16 |
| 280200 | Microform holoprosencephaly | Malformation syndrome | 16 |
| 251576 | Gliosarcoma | Histopathological subtype | 12 |
| 251579 | Giant cell glioblastoma | Histopathological subtype | 13 |
| 251615 | Pilomyxoid astrocytoma | Histopathological subtype | 8 |
HPO Phenotype Associations (393+ terms)
TOP 50 Associated Phenotypes:
| HPO ID | Phenotype |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000044 | Hypogonadotropic hypogonadism |
| HP:0000458 | Anosmia |
| HP:0000028 | Cryptorchidism |
| HP:0000054 | Micropenis |
| HP:0000252 | Microcephaly |
| HP:0000243 | Trigonocephaly |
| HP:0000175 | Cleft palate |
| HP:0000204 | Cleft upper lip |
| HP:0000316 | Hypertelorism |
| HP:0000347 | Micrognathia |
| HP:0000486 | Strabismus |
| HP:0000520 | Proptosis |
| HP:0000586 | Shallow orbits |
| HP:0000365 | Hearing impairment |
| HP:0000470 | Short neck |
| HP:0000508 | Ptosis |
| HP:0000568 | Microphthalmia |
| HP:0000238 | Hydrocephalus |
| HP:0000609 | Optic nerve hypoplasia |
| HP:0000164 | Abnormality of dentition |
| HP:0000677 | Oligodontia |
| HP:0000684 | Delayed eruption of teeth |
| HP:0000717 | Autism |
| HP:0000739 | Anxiety |
| HP:0000716 | Depression |
| HP:0000104 | Renal agenesis |
| HP:0000126 | Hydronephrosis |
| HP:0000125 | Pelvic kidney |
| HP:0000027 | Azoospermia |
| HP:0000134 | Female hypogonadism |
| HP:0000144 | Decreased fertility |
| HP:0000013 | Hypoplasia of uterus |
| HP:0000026 | Male hypogonadism |
| HP:0000047 | Hypospadias |
| HP:0000062 | Ambiguous genitalia |
GWAS Associations (61 associations)
TOP 30 GWAS Traits:
| Study ID | Trait | P-value | Mapped Gene |
|---|
| GCST007995 | Asthma (childhood onset) | 2e-65 | FLG/CCDST |
| GCST010985 | Allergic disease (age of onset) | 3e-82 | FLG/CCDST |
| GCST010984 | Allergic disease (multivariate) | 5e-82 | FLG/CCDST |
| GCST009718 | Eczema | 1e-64 | CCDST |
| GCST007798 | Asthma | 1e-30 | FLG/CCDST |
| GCST007994 | Asthma (age of onset) | 8e-27 | FLG/CCDST |
| GCST008916 | Asthma | 5e-27 | FLG/CCDST |
| GCST002737 | Atopic dermatitis | 2e-25 | CCDST-LCE5A |
| GCST005038 | Allergic disease | 7e-21 | FLG/CCDST |
| GCST010321 | PR interval | 3e-19 | FGFR1-LINC03042 |
| GCST010796 | ECG morphology | 1e-11 | FGFR1 |
| GCST008362 | Birth weight | 8e-11 | FGFR1-LINC03042 |
| GCST006661 | Male-pattern baldness | 1e-10 | PUDPP2-RPTN |
| GCST007045 | PR interval | 5e-10 | FGFR1-LINC03042 |
| GCST006803 | Schizophrenia | 6e-10 | NSD3 |
| GCST009600 | Psychiatric pleiotropy | 2e-9 | FGFR1 |
| GCST004521 | ASD or schizophrenia | 4e-9 | FGFR1 |
| GCST010244 | Triglyceride levels | 4e-9 | FGFR1-LINC03042 |
| GCST010988 | Adult body size | 7e-9 | FGFR1-LINC03042 |
| GCST010989 | Body size at age 10 | 7e-9 | FGFR1-LINC03042 |
| GCST090000047 | Age at first sexual intercourse | 1e-8 | FGFR1-LINC03042 |
| GCST004166 | Nonsyndromic cleft lip/palate | 4e-8 | FGFR1 |
| GCST010118 | Type 2 diabetes | 4e-8 | FGFR1-LINC03042 |
QUICK REFERENCE CARD
╔═══════════════════════════════════════════════════════════════════════╗
║ FGFR1 - QUICK IDENTIFIER CARD ║
╠═══════════════════════════════════════════════════════════════════════╣
║ GENE ║
║ ──── ║
║ HGNC:3688 │ Ensembl: ENSG00000077782 ║
║ Entrez: 2260 │ OMIM: 136350 ║
║ Location: 8p11.23 (38,400,215-38,468,834, minus strand) ║
╠═══════════════════════════════════════════════════════════════════════╣
║ TRANSCRIPT (MANE Select) ║
║ ──────────────────────── ║
║ RefSeq: NM_023110.3 │ Ensembl: ENST00000447712 ║
║ CCDS: CCDS6107 │ Exons: 18 ║
╠═══════════════════════════════════════════════════════════════════════╣
║ PROTEIN ║
║ ─────── ║
║ UniProt: P11362 (reviewed) │ RefSeq: NP_075598 ║
║ Length: 822 aa │ MW: 91,868 Da ║
╠═══════════════════════════════════════════════════════════════════════╣
║ STRUCTURES ║
║ ────────── ║
║ PDB entries: 81 │ AlphaFold: AF-P11362-F1 ║
╠═══════════════════════════════════════════════════════════════════════╣
║ KEY NUMBERS ║
║ ─────────── ║
║ Transcripts: 73 │ Pathways: 22 │ GO terms: 86 ║
║ ClinVar: 1,366+ │ Interactions: 4k+ │ Drugs (Ph4): 23+ ║
╠═══════════════════════════════════════════════════════════════════════╣
║ PRIMARY DISEASES ║
║ ──────────────── ║
║ • Pfeiffer syndrome (craniosynostosis) ║
║ • Kallmann syndrome / Hypogonadotropic hypogonadism ║
║ • Osteoglophonic dysplasia ║
║ • FGFR1-rearranged myeloid/lymphoid neoplasms ║
╠═══════════════════════════════════════════════════════════════════════╣
║ FDA-APPROVED FGFR INHIBITORS ║
║ ──────────────────────────── ║
║ Erdafitinib • Infigratinib • Pemigatinib • Futibatinib ║
╚═══════════════════════════════════════════════════════════════════════╝
Document generated: 2026-04-01
Data sources: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, AlphaMissense, SpliceAI, Reactome, GO, STRING, IntAct, ChEMBL, PharmGKB, Bgee, SCXA, GenCC, Orphanet, HPO, GWAS Catalog,
CollecTRI
I’ve compiled a comprehensive cross-database reference for human FGFR1 covering all 12 sections. Key highlights:
Summary Statistics:
- 73 transcripts (38 protein-coding) with MANE Select: NM_023110/ENST00000447712
- 21 UniProt entries with canonical P11362 (822 aa, 91.9 kDa)
- 81 PDB structures (most X-ray of kinase domain with inhibitors)
- 1,366+ ClinVar variants with ~100 pathogenic/likely pathogenic
- 5,386 AlphaMissense predictions for missense variants
- 22 Reactome pathways (4 disease-related)
- 86 GO terms across biological process, molecular function, and cellular component
- 4,000+ STRING interactions and 232+ IntAct curated interactions
- 23+ FDA-approved drugs that target FGFR1 (including erdafitinib, pemigatinib, futibatinib)
- Ubiquitous expression (292/294 conditions positive) with highest in connective tissue/vasculature
- 5 definitive disease associations: Pfeiffer syndrome, HH2/Kallmann, osteoglophonic dysplasia, Hartsfield syndrome, encephalocraniocutaneous lipomatosis